NGNE
NeurogeneBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
NGNE vs peer average
53/100
NGNE vs. peer average (B vs. B)
Grade spread
A 4 · B 2 · C 3 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ABEO is the first available peer comparator.
Rare-disease gene-therapy biotech with similarly heavy dependence on clinical and regulatory milestones plus financing durability.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NGNE
Neurogene
ABEO
Abeona Therapeutics
Grade
B
B
Momentum
89
70
Value
41
41
Sentiment
40
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs ABEO
NGNE / ABEO
Grade Position
In line
NGNE vs. peer average (B vs. B)
53/100
Momentum
89
NGNEValue
41
NGNESentiment
40
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NGNE
ABEO is the first peer returned for this comparison set.